4
Changes in Ownership
NEOGENOMICS INC Filed Acc 0001077183-22-000049
Chief Financial Officer sold 3,209 shares at $18.29 ($58,693)
- Chief Financial Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bonello William · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-07 | Sale : show line 1 in the form | −3,209 | $18.29 | $58,693 | 98,516 | D |
| 2022-03-08 | Exercise or conversion : show line 2 in the form | +5,000 | $7.52 | $37,600 | 103,516 | D |
| Open-market sales · 3,209 sh · avg $18.29 · $58,693 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-08 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −5,000 | 5,727 | D |
Loading xslF345X03/wf-form4_164686693130490.xml…